MATHEW ABY J. (EVP & Chief Scientific Officer) received a stock award from BIOLIFE SOLUTIONS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/26/2026ACC: 0001628280-26-012473
Officer· EVP & Chief Scientific Officer
Since Mar 2026
+44.12K
Net shares
Net buyer
$353.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
59.70K acquired · 15.59K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20.10K
Price / share
—
Trade value
—
% of position
5.8%
2/24/2026
349.35K→369.45K
Common Stock
Direct
Shares
+39.60K
Price / share
—
Trade value
—
% of position
10.7%
2/24/2026
369.45K→409.05K
Common Stock
Direct
Shares
−15.59K
Price / share
$22.65
Trade value
$353K
% of position
3.8%
2/24/2026
409.05K→393.47K
Total
Net shares
+44.12K
Net value
-$353K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | A · Award | +20.10K | — | — | 5.8% | 349.35K | 369.45K |
| Common Stock Direct | 2/24/2026 | A · Award | +39.60K | — | — | 10.7% | 369.45K | 409.05K |
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −15.59K | $22.65 | $353K | 3.8% | 409.05K | 393.47K |
| Total | +44.12K | -$353K | ||||||
Derivative Transactions0
No derivative transactions reported